Fredun Pharmaceuticals Market Cap ($260.02M USD)
Fredun Pharmaceuticals Market Cap ($260.02M USD). As of Oct. 5, 2026, Fredun Pharmaceuticals (FREDUN) market capitalisation is ₹2340.14 Cr ($260.02M), with 1.72 Cr shares outstanding at a current price of ₹1363.20 on NSE, ranking 1125 out of 5368 companies by market cap in our screener. Fredun Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. Examine FREDUN quarterly performance for recent quarterly revenue, profit and EPS trends.
Market Cap History of Fredun Pharmaceuticals (Last 10 Years)
FREDUN market capitalisation from year-end NSE closing prices over the last 10 years. Compare with FREDUN fundamental valuation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Fredun Pharmaceuticals
FREDUN year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Fredun Pharmaceuticals screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2340.14 Cr
$260.02M USD
|
₹1363.20 | NSE | -13.63% |
| 2025 |
₹2709.39 Cr
$301.04M USD
|
₹1578.30 | BSE | +114.08% |
| 2024 |
₹1265.60 Cr
$140.62M USD
|
₹737.25 | BSE | -15.14% |
| 2023 |
₹1491.34 Cr
$165.70M USD
|
₹868.75 | BSE | -22.45% |
| 2022 |
₹1922.99 Cr
$213.67M USD
|
₹1120.20 | BSE | +32.45% |
| 2021 |
₹1451.86 Cr
$161.32M USD
|
₹845.75 | BSE | +95.21% |
| 2020 |
₹743.74 Cr
$82.64M USD
|
₹433.25 | BSE | +92.30% |
| 2019 |
₹386.76 Cr
$42.97M USD
|
₹225.30 | BSE | -33.17% |
| 2018 |
₹578.68 Cr
$64.30M USD
|
₹337.10 | BSE | +223.20% |
| 2017 |
₹179.05 Cr
$19.89M USD
|
₹104.30 | BSE | +125.51% |
| 2016 |
₹79.40 Cr
$8.82M USD
|
₹46.25 | BSE | - |